Work

Tetrahydrouridine-decitabine for non-cytotoxic epigenetic therapy of NSCLC to enhance immunotherapeutic effect of anti-PD1 in vivo.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.11552

Authors: Kai Kang, David S. Schrump, Anish Thomas, Kurt Alex Schalper, Yogen Saunthararajah, Vamsidhar Velcheti

Institutions: Cleveland Clinic, National Institutes of Health, National Cancer Institute, Yale University, University of Illinois Chicago

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891939646

Cites:

Cited by: 2

Related to: 10